Correlation Between Pasithea Therapeutics and Indaptus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Indaptus Therapeutics, you can compare the effects of market volatilities on Pasithea Therapeutics and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Indaptus Therapeutics.
Diversification Opportunities for Pasithea Therapeutics and Indaptus Therapeutics
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Pasithea and Indaptus is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Indaptus Therapeutics go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Indaptus Therapeutics
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Indaptus Therapeutics. In addition to that, Pasithea Therapeutics is 1.12 times more volatile than Indaptus Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Indaptus Therapeutics is currently generating about -0.03 per unit of volatility. If you would invest 122.00 in Indaptus Therapeutics on October 24, 2024 and sell it today you would lose (36.00) from holding Indaptus Therapeutics or give up 29.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Indaptus Therapeutics
Performance |
| Timeline |
| Pasithea Therapeutics |
| Indaptus Therapeutics |
Pasithea Therapeutics and Indaptus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Indaptus Therapeutics
The main advantage of trading using opposite Pasithea Therapeutics and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |